What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

查看全文 作　　者：Carmine [1,2]Finelli;Giovanni [1,2]Tarantino

机构地区：[1]Center of Obesity and Eating Disorder,Stella Maris Mediterraneum Foundation;[2]Department of Clinical and Experimental Medicine,Federico ⅡUniversity Medical School of Naples

出　　处：《World Journal of Gastroenterology》索引2013年第19卷第6期,共11页

摘　　要：Non-alcoholic fatty liver disease (NAFLD) is recognized as the most common type of chronic liver disease in Western countries.Insulin resistance is a key factor in the pathogenesis of NAFLD,the latter being considered as the hepatic component of insulin resistance or obesity.Adiponectin is the most abundant adipose-specific adipokine.There is evidence that adiponectin decreases hepatic and systematic insulin resistance,and attenuates liver inflammation and fibrosis.Adiponectin generally predicts steatosis grade and the severity of NAFLD;however,to what extent this is a direct effect or related to the presence of more severe insulin resistance or obesity remains to be addressed.Although there is no proven pharmacotherapy for the treatment of NAFLD,recent therapeutic strategies have focused on the indirect upregulation of adiponectin through the administration of various therapeutic agents and/or lifestyle modifications.In this adiponectin-focused review,the pathogenetic role and the potential therapeutic benefits of adiponectin in NAFLD are analyzed systematically. 关键词：Non-alcoholic FATTY liver disease OBESITY ADIPONECTIN VISCERAL fat ADIPOKINES

相关文献

参考文献（140）
引证文献（30）
耦合文献（154）

参考文献(140)

引证文献(30)

耦合文献(154)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

参考文献(140)

引证文献(30)

耦合文献(154)

用户提示